Detalles de la búsqueda
1.
Real-world data for precision cancer medicine-A European perspective.
Genes Chromosomes Cancer
; 62(9): 557-563, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36852573
2.
Protocol of the TREASURE study: Thoracic RadiothErapy with Atezolizumab in Small cell lUng canceR Extensive disease - a randomized, open-label, multicenter phase II trial.
BMC Cancer
; 22(1): 1011, 2022 Sep 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-36153496
3.
Brigatinib versus other second-generation ALK inhibitors as initial treatment of anaplastic lymphoma kinase positive non-small cell lung cancer with deep phenotyping: study protocol of the ABP trial.
BMC Cancer
; 21(1): 743, 2021 Jun 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-34182952
4.
Thoracic radiotherapy plus Durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy - employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy: study protocol of the TRADE-hypo trial.
BMC Cancer
; 20(1): 806, 2020 Aug 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-32842974
5.
Re-irradiation in locally recurrent lung cancer patients.
Strahlenther Onkol
; 195(8): 725-733, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-30937509
6.
Fostering efficacy of anti-PD-1-treatment: Nivolumab plus radiotherapy in advanced non-small cell lung cancer - study protocol of the FORCE trial.
BMC Cancer
; 19(1): 1074, 2019 Nov 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31703637
7.
EML4-ALK fusion variant V3 is a high-risk feature conferring accelerated metastatic spread, early treatment failure and worse overall survival in ALK+ non-small cell lung cancer.
Int J Cancer
; 142(12): 2589-2598, 2018 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29363116
8.
Outcome and prognostic factors in single brain metastases from small-cell lung cancer.
Strahlenther Onkol
; 194(2): 98-106, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29085978
9.
Correction: Thoracic radiotherapy plus Durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy - employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy: study protocol of the TRADE-hypo trial.
BMC Cancer
; 23(1): 740, 2023 Aug 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37563548
10.
Synonymous EGFR variant p.Q787Q is neither prognostic nor predictive in patients with lung adenocarcinoma.
Genes Chromosomes Cancer
; 56(3): 214-220, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-27750395
11.
Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy.
J Neurooncol
; 134(1): 205-212, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28560661
12.
Retrospective study in 23 patients of the self-expanding sinus-XL stent for treatment of malignant superior vena cava obstruction caused by non-small cell lung cancer.
J Vasc Interv Radiol
; 26(3): 357-65, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25638748
13.
Deficient CD247 expression is a typical histopathological characteristic of thymomas with cortical features.
Histopathology
; 73(6): 1040-1043, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30079467
14.
Immune checkpoint inhibitors in non-small cell lung cancer - When should we dare to stop treatment?
Lung Cancer
; 184: 107340, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37657237
15.
Pembrolizumab Alone or With Chemotherapy for 70+ Year-Old Lung Cancer Patients: A Retrospective Study.
Clin Lung Cancer
; 24(7): e282-e290, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37391339
16.
Upfront and Repeated Stereotactic Radiosurgery in Patients With Brain Metastases From NSCLC.
Clin Lung Cancer
; 24(3): 269-277, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36803615
17.
Comorbidity in limited disease small-cell lung cancer: Age-adjusted Charlson comorbidity index and its association with overall survival following chemoradiotherapy.
Clin Transl Radiat Oncol
; 42: 100665, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37564923
18.
High-risk patients with locally advanced non-small cell lung cancer treated with stereotactic body radiation therapy to the peripheral primary combined with conventionally fractionated volumetric arc therapy to the mediastinal lymph nodes.
Front Oncol
; 12: 1035370, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36713565
19.
The impact of TP53 co-mutations and immunologic microenvironment on outcome of lung cancer with EGFR exon 20 insertions.
Eur J Cancer
; 170: 106-118, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35598358
20.
Feasibility and Challenges for Sequential Treatments in ALK-Rearranged Non-Small-Cell Lung Cancer.
Front Oncol
; 11: 670483, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33959513